- Home
- ENLV vs CBUS Comparison
ENLV vs CBUS Comparison
Compare ENLV & CBUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ENLV | CBUS |
|---|---|---|
| Founded | 2005 | 2010 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Agricultural Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 149.0M | 142.7M |
| IPO Year | 2014 | 2017 |
Fundamental Metrics
Financial Performance| Metric | ENLV | CBUS |
|---|---|---|
| Price | $1.11 | $1.61 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 2 |
| Target Price | ★ $20.00 | $9.00 |
| AVG Volume (30 Days) | ★ 268.5K | 122.9K |
| Earning Date | 05-29-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 74.33 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $3,639,000.00 |
| Revenue This Year | N/A | $112.72 |
| Revenue Next Year | N/A | $83.18 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.43 | $1.09 |
| 52 Week High | $7.64 | $4.19 |
Technical Indicators
Market Signals| Indicator | ENLV | CBUS |
|---|---|---|
| Relative Strength Index (RSI) | 31.73 | 37.81 |
| Support Level | $1.00 | $1.49 |
| Resistance Level | $1.26 | $1.60 |
| Average True Range (ATR) | 0.16 | 0.09 |
| MACD | -0.00 | -0.02 |
| Stochastic Oscillator | 4.41 | 24.07 |
Price Performance
Historical ComparisonAbout ENLV Enlivex Therapeutics Ltd.
Enlivex Ltd is a clinical stage macrophage reprogramming immunotherapy company currently focused on the late-stage clinical development of Allocetra, a novel therapy designed to treat the joint disease osteoarthritis. Additionally, it has developed a treasury using the RAIN protocol, which currently serves as the primary treasury reserve asset of the company.
About CBUS Cibus Inc.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.